Gentamicin nephrotoxicity in the rat: Influence of age and diabetes mellitus

Human & Experimental Toxicology

Volumn 15, Issue 1, 1996, Pages 51-55

  Ali, B H ^a   Bashir, A K ^a   El Mugamer, I T ^b   Tanira, M O M ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

age; diabetes; gentamicin; nephrotoxicity; streptozo tocin

Indexed keywords

ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; COPPER; CREATININE; GENTAMICIN; PROTEIN; UREA; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; ENZYME ACTIVITY; INTRAMUSCULAR DRUG ADMINISTRATION; KIDNEY PROXIMAL TUBULE; MALE; MORTALITY; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SENESCENCE; STREPTOZOCIN DIABETES; UREA BLOOD LEVEL; URINARY EXCRETION;

AGING; ANIMALS; ANTI-BACTERIAL AGENTS; BODY WEIGHT; COPPER; DIABETES MELLITUS, EXPERIMENTAL; GENTAMICINS; KIDNEY CORTEX; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; ORGAN SIZE; RATS; RATS, WISTAR; ZINC;

EID: 0030061806     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/096032719601500109     Document Type: Article

References (32)

1. Humes HD Aminoglycoside nephrotoxicity. Kid Internat 1988; 33: 900-911.
2. Mathew T.H. Drug-induced renal disease. Med J Austral 1991; 156: 724-728.
3. Ali BH Gentamicin nephrotoxicity in man and animals: Some recent research. Gen Pharmacol. (in press)
4. Kacew S., Bergeron MG Pathogenic factors in aminoglycoside-induced nephrotoxicity. Toxicol Lett 1990; 51: 241-259.
5. Gouvea W. et al. The protection against gentamicin nephrotoxicity in the streptozotocin-induced diabetic rat is not related to gender. Life Sci 1992; 51: 1747-1758.
6. Zager RA A focus of tissue necrosis increases renal susceptibility to gentamicin administration. Kid Internat 1988; 33: 84-90.
7. Andrews PM, Bates SB Dietary protein as a risk factor in gentamicin nephrotoxicity. Renal Failure 1987; 10: 153-159.
8. Whiting PH et al. The effect of dietary protein restriction on high dose gentamicin nephrotoxicity in rats. B J Exp Pathol 1988; 69: 35-41.
9. Corcoran GB, Salazar DE Obesity as a risk factor in drug-induced organ injury IV. Increased gentamicin nephrotoxicity in the obese overfed rat. J Pharmacol Exp Therapeut 1989; 248: 17-22.
10. Kacew S. Inhibition of gentamicin-induced nephrotoxicity by pyridoxal-5-phosphate in the rat. J Pharmacol Exp Therapeut 1989; 248: 360-365.
11. Ali BH, Bashir AA, Tanira Mom. The effect of thyroxine or carbimazole treatment on gentamicin nephrotoxicity in rats. Hum Exp Toxicol 1995; 14: 13-17.
12. Provoost AP, Adejuyighe O., Wolff ED Nephrotoxicity of aminoglycosides in young and adult rats. Pedia Res 1985; 19: 1191-1196.
13. Beauchamp O. et al. Age-dependent gentamicin experimental nephrotoxicity. J Pharmacol Exp Therapeut 1992; 260: 444-449.
14. Teixeria RG et al. Complete protection from gentamicin-induced acute renal failure in the diabetes mellitus rat. Kid Internat 1982; 21: 600-612.
15. Gouvea W. et al. Insulin reverse the protection given by diabetes against gentamicin nephrotoxicity in the rat. Proc Soc Exp Biol Med 1994; 206: 445-453.
16. Elliot WC et al. Experimental gentamicin nephrotoxicity: effect of streptozotocin-induced diabetes. J Pharmacol Exp Therapeut 1985; 233: 264-270.
17. Ramsammy LS et al. Induction of nephrotoxicity by high doses of gentamicin in diabetic rats. Proc Soc Exp Biol Med 1987; 186: 306-312.
18. Vaamondes CA et al. Effect of duration of diabetes on the protection observed in the diabetic rat against gentamicin-induced acute renal failure. Min Electrol Metab 1984; 10: 209-216.
19. Ali BH, Bashir AK, Tanira Mom. Gentamicin nephrotoxicity in young and old diabetic rats. FASEB 1995; 9: A966.
20. Pariat CP et al. Circadian variation in renal toxicity of gentamicin in rats. Toxicol Lett 1988; 40: 175-182.
21. Gehrig JJ, Ross J., Jamison RL Effect of long-term, alternate day feeding on renal function in aging conscious rats. Kid Internat 1988; 34: 620-630.
22. Davis DF, Shock NW Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest 1950; 29: 496-507.
23. Kyle ME, Kogis JJ The effect of age on salicylate induced nephrotoxicity in male rats. Toxicol Appl Pharmacol 1985; 81: 337-347.
24. Weir BA, Mazumdar DC Aminoglycoside nephrotoxicity following single-dose cytoscopy propylaxis. Ann Pharmacol 1994; 28: 199-201.
25. Sanders TW et al. Lack of in vivo evidence of a cytochrome. P450 metabolite participating in aminoglycoside nephrotoxicity. Biochem Pharmacol 1993; 45: 780-782.
26. Chan MK, Chan KW, Ng WL Amelioration of gentamicin nephrotoxicity by phosopholipids. Nephrol Dial Transplant 1991; 6: 608-614.
27. Gilbert DN et al. Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity. J Infect Dis 1989; 159: 945-953.
28. Hayslett JP Functional adaptation to reduction in renal mass. Physiol Rev 1979; 59: 137-164.
29. Gluck SL, Klahr S. Enlarging our view of the diabetic kidney. N Engl J Med 1991; 324: 1662-1664.
30. Chmielnicka J. et al. Changes in concentration of essential metals in kidneys and urine as indices of gentamicin nephrotoxicity in female Wistar rats. Pharmacol Toxicol 1992; 71: 185-198.
31. Agrawal AK, Rao SS Susceptibility of aging kidney to quinidine. Pharmacol Res 29: 145-154.
32. Abdel Gayoum AA et al. Effect of gentamicin-induced nephrotoxicity on some carbohydrate metabolic pathways in the rat renal cortex. Arch Toxicol 1994; 68: 643-647.